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Abstract
Background:
Software to help control diabetes is currently an embryonic market with the main activity to date focused 
mainly on the development of noncomputerized solutions, such as cardboard calculators or computerized 
solutions that use “flat” computer models, which are applied to each person without taking into account their 
individual lifestyles. The development of true, mobile device-driven health applications has been hindered 
by the lack of tools available in the past and the sheer lack of mobile devices on the market. This has now 
changed, however, with the availability of pocket personal computer handsets.
Method:
This article describes a solution in the form of an intelligent neural network running on mobile devices, 
allowing people with diabetes access to it regardless of their location. Utilizing an easy to learn and use 
multipanel user interface, people with diabetes can run the software in real time via an easy to use graphical 
user interface. The neural network consists of four neurons. The first is glucose. If the user’s current glucose 
level is within the target range, the glucose weight is then multiplied by zero. If the glucose level is high, 
then there will be a positive value multiplied to the weight, resulting in a positive amount of insulin to be 
injected. If the user’s glucose level is low, then the weights will be multiplied by a negative value, resulting in a 
decrease in the overall insulin dose.
Results:
A minifeasibility trial was carried out at a local hospital under a consultant endocrinologist in Belfast. 
The short study ran for 2 weeks with six patients. The main objectives were to investigate the user interface, 
test the remote sending of data over a 3G network to a centralized server at the university, and record patient 
data for further proofing of the neural network. We also received useful feedback regarding the user interface 
and the feasibility of handing real-world patients a new mobile phone. Results of this short trial confirmed to a 
large degree that our approach (which also can be known as intensive insulinotherapy) has value and perhaps 
that our neural network approach has implications for future intelligent insulin pumps.
continued 
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Introduction
The International Diabetes Federation1 estimated that 
there were 30 million people with diabetes in 1985. It now 
affects approximately 194 million people worldwide.2 In just 
20 years, the number of people with diabetes increased 
over six times. The number of people who have diabetes 
is expected to more than double from its current number 
within the next 25 years. Beaglehole and Lefèbvre3 from 
the World Health Organization and International Diabetes 
Foundation have announced that “the world is facing a 
growing diabetes epidemic of potentially devastating 
proportions.”
Diabetes is a metabolic disorder. The body digests 
carbohydrates in food that has been eaten and moves 
the by-product (glucose) into the blood. From circulation 
of the blood, glucose can be used or stored by any part 
of the body. Glucose is the body’s main energy source 
and is moved from the blood into cells by insulin. 
The amount of insulin in the body of an individual with 
diabetes is either in inefficient supply or nonexistent. 
Many people with diabetes are faced with having to 
inject insulin in order to live. If too much insulin is 
injected, there will not be enough glucose in the blood. 
If too little insulin is injected, there will be an oversupply. 
Both circumstances can have fatal consequences. It is very 
important that insulin-dependent people with diabetes 
inject a proper amount of insulin. As the amount of 
glucose in the blood is dynamic, the ideal amount of 
insulin to inject should not be static—it should match the 
rise and fall of glucose. If a dynamic amount of insulin 
is injected, how is a person with diabetes to know the 
amount to inject? As this is a metabolic problem and 
people have different metabolic rates, the answer cannot be 
a “one size fits all” solution. This current health problem 
requires an “intelligent” solution—a program that is able 
to learn about how each unit of insulin affects its current 
user.
We propose a solution in the form of an artificial neural 
network. We have knowledge of the concentration of 
glucose there should be in the blood. With a desired result 
and an ability to read the current amount of glucose, 
an error rate can be found. The error rate can be used 
to adjust the weights of inputs that affect the glucose 
level. This feedback and changing of weights can cause a 
neural network to learn and adapt itself to every user. 
The current method of guessing a dynamic amount of 
insulin to inject can then be replaced by this intelligent 
solution. The emergence of personal computers into our 
daily lives in the past 20 years means that this neural 
network program can be implemented for the first time 
in history. Even now, most people are not in front of a 
computer at all times of every day; however, within the 
past few years, mobile phones have become our mini-
computers with ever-increasing memory and processing 
power. Because most people have mobile phones with 
them throughout the day, this is an ideal platform for 
something people will need at any time of the day.
A study done in 2006 by the American Diabetes Association 
said one in three Americans has diabetes or a precursor 
to the disease. Untreated, diabetes can be fatal or cause 
blindness and circulation problems. This therefore 
makes it difficult to “quantify” the value to a customer. 
However, a study by Feltbower and colleagues4 found 
that if 1% of current patients under the age of 15 years 
with diabetes were to move onto insulin pump therapy, 
this would impose an additional cost of £400–1300 per year 
for each primary care trust. Therefore, the additional 
resources required to pay for a solution such as proposed 
Abstract cont.
Conclusions:
Currently, there is no software available to tell people with diabetes how much insulin to inject in accordance 
with their lifestyle and individual inputs, which leads to adjustments in software predictions on the amount 
of insulin to inject. We have taken initial steps to supplement the knowledge and skills of health care professionals 
in controlling insulin levels on a daily basis using a mobile device for people who are less able to manage 
their disease, especially children and young adults.
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here for a small proportion of the diabetes population 
would be minimal given the potential benefits to these 
patients of improved control and anticipated reduction in 
long-term morbidity.
Health care is the most information-intensive of industries 
and is evolving rapidly as new information supplants 
old information. The mobile phone may be the perfect 
platform for applications such as remote medical monitoring, 
home screening tests, “lite” telemedicine visits, medication 
management, patient education, and, specifically here, 
diabetes management. Already, a number of medical 
device manufacturers and mobile phone companies 
have joined forces to develop and pilot various kinds of 
applications using specially configured mobile phones, 
services, and Bluetooth-enabled physiological sensors such 
as blood glucose meters, cardiac monitors, sleep apnea 
detectors, exercise and dietary intake monitors, peak flow 
meters for asthma management, cuffless blood pressure 
monitors for hypertension screening, and medication 
management dispensers. All of this holds great promise 
for the system described here.
Diabetes
How does an insulin-dependent diabetic individual know 
when he/she injects insulin how much glucose will 
be in his/her blood later in the day? This is the major 
disadvantage insulin-dependent people with diabetes 
have—predicting the future. On paper, this would be 
best handled by eating the same amount of carbohydrates 
at the same time each day and exercising, which 
increases the absorption of glucose in the muscle cells, 
the same amount every day. However, in reality, this 
7-day-a-week static routine can range from being very 
awkward to nearly impossible.5 The insulin-dependent 
diabetic individual has the following choices:
1. Live with this restrictive plan, eating the same number 
of carbohydrates and getting the same amount of 
exercise at the same time every day.
2. Follow a more normal, dynamic lifestyle while guessing 
the amount of insulin to have.
While the second choice is more ideal, it comes at a heavy 
price. The guess might be wrong. If too much insulin is 
injected, there will not be enough glucose in the body. 
This affects the brain first and foremost. Unlike muscles, 
the brain does not store glycogen. The brain is almost 
entirely dependent on glucose (in the blood) for normal 
functioning.6 If the amount of glucose in the blood is too 
low, the brain does not function as well. If the amount 
of glucose continues to drop beyond a certain level, a 
coma will result. If too little insulin is injected, there 
will be too much glucose in the blood, which results in 
every organ in the body being harmed over time. Let us 
suppose that a hypothetical, insulin-dependent diabetic 
individual follows the first choice. If he/she tested his/her 
glucose level in the morning and it was high, the best 
thing he/she could do is inject more short-term insulin to 
bring the high amount of glucose down. Let us suppose 
he/she usually sits at a desk at work every day, but has 
this day off work. If he/she wanted to hike in hills in the 
afternoon, he/she would either have to have less insulin 
before the activity or have to eat more carbohydrates in 
the afternoon to compensate for the exercise. These two 
situations—being in need of more and less insulin—can 
best be resolved by following a dynamic insulin regime.
Factors Affecting Insulin Need
Three main factors are involved in deciding how much 
insulin a person with diabetes would need to inject7: 
(1) current glucose level, (2) future amount of carbohydrates 
to be eaten, and (3) future amount of exercise. As the first 
two items rise, the amount of insulin should also rise. 
As the third item rises, the amount of insulin should 
decrease. The reverse is also true for all these factors. 
A few other minor factors, such as a disruption to the 
sleep pattern and a high stress level, can affect glucose 
levels. However, as the American Diabetes Association5 
reports, because these factors can affect glucose levels 
in an unpredictable way, insulin cannot always be 
predicatively adjusted for these other factors.
Current Glucose Level. Ideally, any time the level of 
glucose in the blood is raised, there should be extra fast-
acting insulin injected to counter the raised glucose—
more glucose resulting in more insulin. This is, after all, 
how the body of a person without diabetes maintains 
the balance of glucose in the bloodstream. If, contrary to 
this, the amount of glucose is low, then less fast-acting 
insulin should be injected. The lower the level of glucose, 
the less insulin should be injected—as long as a “basal” 
amount of insulin is always present in the blood.
Future Amount of Carbohydrates To Be Eaten. The more 
carbohydrates a person eats, the more insulin should 
be injected to counteract the higher amount of glucose in 
the blood. Eating a meal with many carbohydrates results 
in proportionally more glucose in the blood. Eating a light 
meal, such as a salad, with little or no carbohydrates 
would put little or no glucose in the blood and would thus 
require little or no insulin to counteract such a meal. 
There is an additional factor at work in the digestion of 
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carbohydrates—the glycemic index. This index accounts 
for how quickly carbohydrates are digested into glucose.8 
For purposes of adjusting insulin levels, the glycemic 
index only needs to be taken into consideration if the 
person with diabetes intends to eat food with a very 
high or very low glycemic index shortly before the 
4-hour period after injecting insulin. If food has a very 
high glycemic index and will be consumed 3.5 hours 
after injecting insulin, it might fall into the short-term 
insulin range; otherwise it might not be digested until 
after a longer term insulin range begins. Although some 
carbohydrates are digested more quickly than others, for 
our purposes of controlling blood glucose, a carbohydrate 
is a carbohydrate is a carbohydrate.9,10
Future Amount of Exercise. Exercise reduces the amount 
of glucose in the bloodstream. Exercise helps transport 
glucose into working muscle cells, and muscle contraction 
has some of the same effects as insulin.11 The more 
exercise that is taken, the more glucose is transported 
into the muscle cells. This causes the body to need less 
insulin to transport the same amount of glucose out of the 
bloodstream—a state of insulin sensitivity. Contrary to 
this, reduced exercise moves less glucose into muscle 
cells—similar to insulin resistance in people with type 2 
diabetes. Other factors affect the amount of glucose in 
the blood. One of these is the changing metabolic 
rate of the body throughout the day. There is a whole 
field of study devoted to this called chronobiology.12
Chronobiology has found “overwhelming” evidence 
that daily variations of human physiology (including 
heartbeat frequency, blood pressure, body temperature, 
renal activity, liver metabolism, and the secretion of 
many hormones), as well as the incidence and severity 
of many diseases, have an underlying circadian basis.13 
This “circadian basis” is our body’s 24-hour cycle. 
A meal eaten in the morning may need a different 
amount of immediate insulin than if it were eaten at 
night. This is something that can be observed in a neural 
network.
Related Work
The unique technological aspect of this project is to 
incorporate neural network-driven software, which is 
fronted by an intuitive user interface that strives to 
make the application simple and accessible for both the 
user and the clinician. Existing offerings do not offer the 
end-to-end package of Intelligent Neural Network for 
Suggesting Unambiguous Levels of Insulin via Needle 
(INNSULIN), which offers not only an intuitive user 
interface on a mobile phone, but also the communication 
of data to a central server where data are analyzed 
and presented to the user and clinician in a usable and 
user-friendly format. There are competitors but they 
are fragmented in terms of the end user profile their 
products address.
InsuCalc is a small cardboard calculator. Patients turn 
a disk representing the amount of carbohydrates about 
to be eaten in order to get a result of the amount of 
insulin to inject. InsuCalc uses the selling point that it 
is “nonelectronic, fits in a pocket”; however, the output 
is only for short-term insulin. Therefore, any person who 
injects long-term insulin would not get any benefit from 
this product for periods over 4 hours.
Another related product is the Diabetes Mentor from 
Mimosa Wireless Ltd. This application, however, is more 
of an intelligent tutoring system that mentors people 
with diabetes in an attempt to give them the ability to 
develop the necessary expertise to manage their intake. It 
contains a minimal knowledge of managing diabetes 
and has not yet moved beyond the prototype stage.
Online Tools
The vast majority of tools are online calculators of some 
sort. Most do not have applications targeted at the mobile 
phone market. For instance, the DiabetesNet Wizard tool 
assesses current insulin doses and gives suggestions 
on how they might be changed to improve control. 
Users enter the total units of insulin used each day 
along with control patterns. My Sugar Level is an online 
tracking and charting service for all people with diabetes. 
It is a visual management tool but no mobile phone 
application exists.
Personal Device Assistance Software
UTS Diabetes is Palm personal device assistance software 
that tracks the user’s blood glucose level, insulin injections, 
carbohydrates consumed, medication intakes, and other 
diabetes statistics. Its purpose, however, is to serve as 
a traditional paper diabetic logbook. Diabetes Pilot is 
Palm software that helps users see trends in their 
blood sugars with various reports and graphs. It also 
categorizes records by time of day or any other system 
that the user requests. This again is more a diary and is 
not “active” in the sense of INNSULIN.
Insulin Pumps
An insulin pump is a small device about the same 
size as a pack of cards, which looks similar to a pager. 
Inside is a reservoir containing insulin, which is attached 
via a long piece of thin tubing. At the end of this tubing 
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is a needle or cannula inserted under the skin, enabling 
insulin to flow into the body. The pump is not automatic, 
but is programmed to deliver insulin constantly at varying 
rates that the user determines; however, there are problems.
Because insulin pumps use the very fast-acting lispro 
insulin, which only lasts 3 to 4 hours after injection, 
diabetic ketoacidosis (DKA), a life-threatening condition 
caused by a lack of insulin, becomes a real possibility 
if the pump stops delivering the required amount of 
insulin. DKA could happen if (1) the pump tubing 
becomes blocked or comes out from under the skin or 
(2) the cartridge is allowed to run out of insulin.
We believe that no other company is utilizing neural 
network-based software for mobile phones in the control 
of diabetes insulin intake.
Neural Network
What is needed for a more accurate projection of insulin 
requirements is for exercise, current glucose level, 
intended carbohydrate intake, and period of the day to be 
used as inputs. There should be feedback based on any 
glucose testing within the next several hours so that 
the product can “learn” and adjust itself to the user. 
A patient with increased insulin sensitivity will require 
less insulin, even given the same inputs. A patient with 
increased insulin resistance will need more insulin. 
The insulin sensitivity/resistance will differ from person 
to person and with one person over time. Also, given 
the same inputs and insulin sensitivity/resistance, 
two insulin-dependent people with diabetes will also 
require different amounts of insulin based on their 
mass. For example, if one diabetic individual weighs 
7 stone, another weighs 14 stone, and they both have the 
same percentage of glucose in their blood, the person 
who weighs twice as much will generally have twice as 
much glucose in the blood, which will result in generally 
needing twice as much insulin.
The neural network consists of four neurons. The first 
is glucose. If the user’s current glucose level is within 
the target range, the glucose weight is then multiplied 
by zero. If the glucose level is high, then there will be 
a positive value multiplied to the weight, resulting in a 
positive amount of insulin to be injected. If the user’s 
glucose level is low, then the weights will be multiplied 
by a negative value, resulting in a decrease in the 
overall insulin dose. The long-term “basal” dose will 
be removed completely from the network so that there 
will always be a guaranteed minimal amount of insulin 
present in the body, regardless of how low the glucose 
level falls. The weight will answer the question “how 
much insulin is required to lower the glucose level by 
1 unit?” This way, for every unit the current glucose is 
above the target range, the adapting weight will output 
how much insulin is needed to move the glucose to the 
target range.
The second neuron is the carbohydrate neuron. The weight 
of this neuron is the amount of insulin required to keep 
the amount of glucose in the bloodstream at the same 
level for every carbohydrate eaten. If, for example, the 
user of the program was going to eat 10 carbohydrates, 
then this number would be multiplied by the carbohydrate 
weight to output the required amount of insulin needed 
to nullify the 10 carbohydrates from the bloodstream. 
The amount of insulin for the glucose output could be:
1. positive for a high glucose reading
2. zero for an “in the target zone” glucose level
3. negative if the current glucose level is low
The carbohydrate neuron can only be:
1. positive if the user is going to eat carbohydrates
2. zero if the user will not be eating any carbohydrates
After the glucose and carbohydrate outputs are computed, 
results are summed. A negative result is possible if 
the user has a low glucose level and will not eat many 
carbohydrates. If this is the case, then the final result 
of insulin to inject will automatically be zero units. 
A diabetic individual cannot, after all, inject a negative 
amount of insulin. It might be a good idea for the 
program in this case to recommend the user eat a 
calculated amount of carbohydrates in order to raise the 
glucose level to the target range.
The exercise neuron is the most challenging. After the 
glucose and carbohydrate outputs are summed, the 
result is divided by the number of minutes in the acting 
range of the short-term insulin. This gives the amount 
of insulin that will be working—on average—for 
each minute over the course of the range of the dose. 
Exercise intensities have been divided into 13 categories. 
The lowest number, which is 1, would be for “sitting 
around” type of activities, and the highest number 
would be for the most physically demanding activities. 
Exercise intensity is multiplied by the weight of the 
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exercise. This solution would work if it was linear; 
however, the difference in the effect in glucose may not 
be—a straight line on a graph—linear.
To explain this using an oversimplified, hypothetical 
situation, let us suppose the weight for exercise is 1.0. 
A person is to be at activity level 1 for an hour. Then the 
person is going to participate in an activity at level 2 for 
an hour. Training at exercise level 2 would output exactly 
half of the insulin required than the time spent at level 1. 
If the solution is a linear one, then exercising at activity 
level 4 would require half the insulin again. Training at 
level 8 would require half the insulin than that of level 4. 
If the solution to exercise is a linear one, then this would 
work perfectly. Through thorough searching, no evidence 
was found to show how exercise should be computed.
Our solution, which caters to both linear and nonlinear 
weights, is to have 13 different weights. Whichever level 
of activity a person participates in will be multiplied by 
the weight of that level. During the update of weights, 
only the weights of those levels will be updated. A cleaner, 
single weight, quadratic equation can then be implemented 
after rigorous testing is complete on this setup. After 
the level is multiplied by the weight, the result is then 
multiplied by the duration. The output from this calculation 
is a percentage of total insulin to inject for the activity 
duration. The amount of insulin per minute is multiplied 
by the duration and then multiplied by the percentage. 
After then dividing by 100, the exercise portion of the 
neuron is complete.
The weight of the time neuron is an array of size 24—
one for each hour. The array value for that time will 
be multiplied by the result after the exercise neuron. 
The value will be a double data type very near 1.0, 
which is the value all of the weights will start off with. 
This will cater to the metabolism of the body for 
different times of the day and will affect the overall 
insulin dose very slightly. The National Health Service14 
recommends that the level of glucose in the blood of an 
individual with diabetes be “between 4 and 7 mmol/liter 
before meals and less than 10 mmol/liter 2 hours 
after meals.” This is the target for the neural network. 
We adopt an error-correction rule that, as Kecman15 
states, “changes the weights proportional to the error 
e = d – o between the actual output o and the desired 
output d.” Every time a blood glucose test is taken, 
the result is entered into the neural network and is 
subtracted from the target (desired) output and the error 
will then change the weights (unless desired output 
equals target output).
INNSULIN
INNSULIN is a java application for mobile phones, 
as we believe that there would be very few people 
with diabetes who would sit in front of their personal 
computer every waking hour. However, programs can 
be written, stored, and run on mobile phones, and 
these phones are in the hands of a large majority of the 
population. The introduction screen for mobile phones 
is shown in Figure 1A.
After pressing the “Start” button, the user arrives at the 
glucose screen shown in Figure 1B. To maneuver from 
the regular user interface (UI) to the help UI, the user 
only has to push the joystick to the right. To move back 
involves pushing the joystick to the left, as illustrated in 
Figure 1C.
The user will select their food through a list sourced 
from the U.S. Department of Agriculture16 of over 7000 
foods with their nutritional values. Two thousand foods 
were removed from this list, such as pop-corn, salted, as there 
is no carbohydrate content in salt. We wanted the user to 
be able to look up this list to select their food because 
most users might not know the carbohydrate count 
of many foods, but it would be embedded for them to 
use—on the list (see Figure 1D). After selecting the 
food that will be eaten, the user then has to select how 
many servings they will eat, as shown in Figure 2A and 
Figure 2B. The “Options” screen is shown in Figure 2C. 
If the user cannot find the correct food they intend to 
eat, but knows the carbohydrate count of the food, they 
can select the “Input Carbs” option as illustrated in 
Figure 2D. The exercise component is broken down into 
13 user-selectable categories. A list of many activities 
(from carpet sweeping to flying an airplane) and the 
amount of calories each of the activities expend is 
used. Activity level 1 (basically sitting around) is shown 
in Figure 3A. The next level of activity is shown in 
Figure 3B. Figure 3C and 3D show higher levels of 
exercise activity.
After the activity is selected, the user must enter what 
time the activity will begin—starting at the current 
time, as shown in Figure 4a. After this, the user must 
select what time the activity will last, as illustrated in 
Figure 4B.
The network then calculates the correct dose and 
displays results to the user, as shown in Figure 4C. 
Figure 4D confirms in this case that all data are up to 
date. If, however, the program is in the “training” stage, 
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Figure 1. INNSULIN initial screenshots.
Figure 2. Selecting servings.
the next screen will involve asking the user how much 
she/he intends to inject.
Evaluation
A minifeasibility trial was carried out at a local hospital 
under a consultant endocrinologist in Belfast. The short 
study ran for 2 weeks with six patients. The main 
objectives were to investigate the user interface, test 
the remote sending of data over a 3G network to a 
centralized server at the University of Ulster, and record 
patient data for further proofing of the neural network. 
We also received useful feedback regarding the user 
interface and the feasibility of handing real-world patients 
a new mobile phone.
Results of this short trial confirmed to a large degree 
that our approach (which also can be known as intensive 
insulinotherapy) has value and that perhaps our neural 
network approach has implications for future intelligent 
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Figure 3. Exercise activity level screens.
Figure 4. Activity start and end times.
insulin pumps. Indeed, lately, the United Kingdom 
Prospective Diabetes Study demonstrated that intensive 
insulinotherapy has a protective value in ameliorating 
frequency and severity of macro- and microvascular 
complications of diabetes mellitus. The method of 
intensive insulinotherapy is based on multiple injections 
of rapid-acting insulin before each meal and a once-
daily dose of long-acting insulin as a baseline dose. 
Close monitoring of blood glucose with several times 
a day performed tests is indispensable. Our system 
provides all the inputs necessary to assist those who are 
following this approach.
A key feature of our solution is the ability to store large 
amounts of past glucose results. The field of diabetes 
care is arguably the most chronically data-intensive 
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discipline in medicine. Our current system has worked 
well in a preliminary trial with Ulster Hospital and 
allows results to be sent in real time from a phone to 
a secure Web site where the consultant endocrinologist can 
view the insulin levels of each patient. This resulted in 
the most favorable feedback to date from those involved, 
as previously they relied on feedback from the patients, 
which obviously had to be taken on trust.
We have had initial discussions with companies working 
in the field of software development for the health care 
market, with one in particular declaring that they have 
development plans for a similar product, but without 
our unique feature of using a neural network. The office 
of innovation at the university also commissioned a 
preliminary report from external consultants and revealed 
some positive findings for the INNSULIN concept.
Future Work
There is a drive to use online technology to expand patient 
knowledge and support patient–physician communication 
to improve diabetes management and treatment outcomes. 
Stanley and Malakar17 have shown that monitoring 
glucose levels from patients’ homes resulted in participants 
reporting high levels of satisfaction and were more 
likely to monitor their blood glucose levels regularly. 
They were also more knowledgeable about their condition 
and more confident in their ability to control their blood 
glucose.
This project will integrate home-based glucose monitoring 
results securely and easily within the clinical workflow 
of diabetes care. Glucometers and blood pressure devices 
linked to smartphones and iPhones will transmit personal 
health data into our secure clinical server side diabetes 
management application. Currently, our system can deal 
with at least two kinds of insulin inputs (see Figure 5). 
This is because patients use two kinds of insulin together: 
one for background and one for the meal. To calculate 
the dosage of the insulin, we use a neural network.
A number of key areas need to be focused on to allow 
us to reach the commercialization stage:
1. Accumulate longer term insulin data from clinical 
data sets to train the neural network.
2. Add fuzzy logic to the system to ensure that 
predictions are accurate.
3. Add a “startup” mathematical formula to product 
a general result and then use the neural network to 
fix the mistake, which will raise the accuracy of the 
neural network.
4. Conduct more visits to hospitals and clinics. Speak to 
doctors and patients to ascertain what system is most 
needed and how a system such as this can be developed 
to be useful and convenient as a real-time monitoring 
tool for both patient and clinician.
5. Continue testing of current interface.
6. Build a kind of program called “diabetes diary”; this 
kind of software is only used to collect information 
for training the neural network.
7. Use MATLAB to find a proper mathematic model and 
the structure of the neural network from data and 
then implement it.
8. Build another demo (see Figure 6) and add the 
calculation function.
9. Loop: test, update program, and support different 
kinds of mobile phones, including the iPhone.
Our unique application of a modified Levenberg–
Marquardt method to train the neural network and the 
integration of wireless glucometers in the system are 
especially worth investigating further. A more detailed 
outline of the neural network is outlined in Appendix A.
Figure 5. Current system model. Figure 6. Planned system model.
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Conclusion
The prediction is that application development for 
mobile devices will explode, with high growth in social, 
recreational, and educational applications. The mobile 
market offers considerable potential for educational 
applications with an emergent trend in mobile learning 
for supporting health and leisure activities. There is 
growing governmental awareness of the need for patients 
with chronic or long-term health conditions to become 
skilled at managing their own condition instead of 
relying on the intervention of health care professionals. 
Diabetes is a critical illness that is being diagnosed 
throughout society at a very large rate. It is a result of the 
body not being able to transport digested carbohydrates 
to where they can be used or stored. For many people 
with diabetes, the only way to continue living with this 
illness is to inject insulin. Currently, there is no software 
that tells people with diabetes how much insulin to inject 
in accordance with their lifestyle and individual inputs, 
which lead to adjustments in software preductions on 
an amount of insulin to inject. INNSULIN attempts 
to supplement the knowledge and skills of health care 
professionals in controlling insulin levels on a daily 
basis using a mobile device for people who are less able 
to manage their disease, especially children and young 
adults.
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Appendix A
(1) Hard limit or step function:
y = f (net) = 
⎧
⎨
⎩
+1 if net ≥ 0
0 if net < 0
(2) Symmetric hard limit function:
y = f (net) = 
⎧
⎨
⎩
+1 if net ≥ 0
–1 if net < 0
(3) Linear function:
y = f (net) = k • net
where k is a constant.
(4) Symmetric saturating linear or ramp function:
y = f (net) = 
if net > upper limit
if upper limit > net > lower limit
if net < lower limit
⎧
⎨
⎩
max
k • net
min
Figure 7. Outline of neural network. CH, carbohydrate.
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(5) Sigmoid function
y = f (net) = 1
1 + e–net
(6) Hyperbolic tangent or tan–sigmoid function
y = f (net) = 2
1 + e–net
 – 1 = 1 – e
–net 
1 + e–net
Appendix A
